CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials (Chinese version)

Kenneth F. Schulz, Douglas G. Altman, David Moher, Virginia Barbour, Jesse A. Berlin, Isabelle Boutron, P. J. Devereaux, Kay Dickersin, Diana Elbourne, Susan Ellenberg, Val Gebski, Steven Goodman, Peter C. Gøtzsche, Trish Groves, Steven Grunberg, Brian Haynes, Sally Hopewell, Astrid James, Peter Juhn, Philippa MiddletonDon Minckler, Victor M. Montori, Cynthia Mulrow, Stuart Pocock, Drummond Rennie, David L. Schriger, Iveta Simera, Elizabeth Wager, Mike Clarke, Gordon Guyatt

Research output: Contribution to journalArticlepeer-review

99 Scopus citations

Abstract

The CONSORT statement is used worldwide to improve the reporting of randomised controlled trials. Kenneth Schulz and colleagues describe the latest version, CONSORT 2010, which updates the reporting guideline based on new methodological evidence and accumulating experience. To encourage dissemination of the CONSORT 2010 Statement, this article is freely accessible on bmj.com and will also be published in the Lancet, Obstetrics and Gynecology, PLoS Medicine, Annals of Internal Medicine, Open Medicine, Journal of Clinical Epidemiology, BMC Medicine, and Trials.

Original languageEnglish (US)
Pages (from-to)604-612
Number of pages9
JournalJournal of Chinese Integrative Medicine
Volume8
Issue number7
DOIs
StatePublished - Jul 2010

Keywords

  • CONSORT
  • Clinical trials
  • Guidelines
  • Randomized controlled trials

ASJC Scopus subject areas

  • Complementary and alternative medicine

Fingerprint

Dive into the research topics of 'CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials (Chinese version)'. Together they form a unique fingerprint.

Cite this